Background The use of percutaneous coronary intervention (PCI) in patients with ST‐
segment elevation myocardial infarction (STEMI) is associated with a mortality rate of 5 …

In the past 10 years, mortality from acute myocardial infarction has not decreased despite
the widespread introduction of percutaneous coronary intervention. The reason for this …

Previous studies have reported that microRNA-22 (miR-22) may be implicated in ischemia-
reperfusion (I/R)-induced myocardial injury. Our previously published data also …

Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …

There are various studies that have addressed the use of Cyclosporine among patients with
acute myocardial infarction (AMI). However, to date there is hardly any concise and …

ST-segment elevation myocardial infarction is a major cause of morbidity and mortality
worldwide. Reperfusion injury (RI) following the opening of an occluded coronary artery …

Objective: Currently, there is still no effective strategy to diminish the infarct size (IS) in
patients with ST-segment elevation myocardial infarction (STEMI). According to a previous …

AIM To assess the prevalence of depressed heart rate variability (HRV) after an acute
myocardial infarction (MI), and to evaluate its prognostic significance in the present era of …

Abstract Purpose of the Review This review aims to evaluate current evidence regarding
ventricular tachycardia ablation in patients with ischemic heart disease and explore novel …

Objective Few studies have focused on the effects of an improved door-to-balloon time on
clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). The …